---
$id: https://graph.org.ai/products/commodity/51162633
$type: Product
source: UNSPSC
code: "51162633"
title: "Levodropropizine"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levodropropizine

**UNSPSC Code**: 51162633
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C13H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3O31P6T4G3, chemically known as 1,2-propanediol, 3-(4-phenylpiperazin-1-yl)-, s(-)- but more generally known as levodropropizine, which bears US NIH Compound Identifier 65859. European Medicines Agency schedules Levodropropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12105MIG. The term LEVODROPROPIZINE is an International Non-Proprietary Name. World Health Organization schedules levodropropizine in its Anatomical Therapeutic Chemical (ATC) Classification. LEVODROPROPIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule levodropropizine under HS 29335995 and SITC 51576. As of Q4 2014, LEVODROPROPIZINE remains US FDA's Preferred Term for this commodity. Levodropropizine bears US NLM identifiers UMLS ID C0125654 and NCI Concept Code C81593. SMILES: OC(CN1CCN(CC1)C1CCCCC1)CO.

